A novel carbohydrate-deficient glycoprotein syndrome characterized by a deficiency in glucosylation of the dolichol-linked oligosaccharide.
Open accessThe DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Abstract
Carbohydrate-deficient glycoprotein syndromes (CDGS) type I are a group of genetic diseases characterized by a deficiency of N-linked protein glycosylation in the endoplasmic reticulum. The majority of these CDGS patients have phosphomannomutase (PMM) deficiency (type A). This enzyme is required for the synthesis of GDP-mannose, one of the substrates in the biosynthesis of the dolichol-linked oligosaccharide Glc3Man9GlcNAc2. This oligosaccharide serves as the donor substrate in the N-linked glycosylation process. We report on the biochemical characterization of a novel CDGS type I in fibroblasts of four related patients with normal PMM activity but a strongly reduced ability to synthesize glucosylated dolichol-linked oligosaccharide leading to accumulation of dolichol-linked Man9GlcNAc2. This deficiency in the synthesis of dolichol-linked Glc3Man9GlcNAc2 oligosaccharide explains the hypoglycosylation of serum proteins in these patients, because nonglucosylated oligosaccharides are suboptimal substrates in the protein glycosylation process, catalyzed by the oligosaccharyltransferase complex. Accordingly, the efficiency of N-linked protein glycosylation was found to be reduced in fibroblasts from these patients.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Niehues, R., Hasilik, M., Alton, G., Körner, C., Schiebe-Sukumar, M., Koch, H. G., Zimmer, K. P., Wu, R., Harms, E., Reiter, K., et al. (1998) · Journal of Clinical Investigation · doi:10.1172/jci2350 · Cited by 422 · cited 2×
“Recently, the CDGS type Ib was described and assigned to a deficiency in phosphomannoisomerase, an enzyme required in GDP-mannose biosynthesis before phosphomannomutase (19).”
BackgroundResultJaeken, J., van Eijk, H. G., van der Heul, C., Corbeel, L., Eeckels, R., & Eggermont, E. (1984) · Clinica Chimica Acta · doi:10.1016/0009-8981(84)90059-7 · Cited by 280 · cited 2×
“rum transferrin was performed as described (6).”
BackgroundSelf-citationPanneerselvam, K., & Freeze, H. H. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118570 · Cited by 146
A new variant of the carbohydrate deficient glycoproteins syndrome
Ramaekers, V. T., Stibler, H., Kint, J., & Jaeken, J. (1991) · Journal of Inherited Metabolic Disease · doi:10.1007/bf01811710 · Cited by 66
Self-citation
Cited by
Marquardt, T., & Denecke, J. (2003) · European Journal of Pediatrics · doi:10.1007/s00431-002-1136-0 · Cited by 290
Congenital disorders of glycosylation: genetic model systems lead the way
Aebi, M. (2001) · Trends in Cell Biology · doi:10.1016/s0962-8924(01)01925-0 · Cited by 167
Self-citationUpdate and perspectives on congenital disorders of glycosylation
Freeze, H. H. (2001) · Glycobiology · doi:10.1093/glycob/11.12.129r · Cited by 156
“About 20 patients have been shown to have a deficiency in α1,3 glucosyl transferase (Burda et al., 1998; Körner et al., 1998a; Grünewald et al., 2000; Hanefeld et al., 2000; Imbach et al., 2000a; Westphal et al., 2000a,b).”
BackgroundRush, J. S., Panneerselvam, K., Waechter, C. J., & Freeze, H. H. (2000) · Glycobiology · doi:10.1093/glycob/10.8.829 · Cited by 63
Metadata
- Authors
- Burda, P., Borsig, L., de Rijk-van Andel, J., Wevers, R., Jaeken, J., Carchon, H., Berger, E. G., & Aebi, M.
- Venue
- Journal of Clinical Investigation
- Published
- 1998-08-15
- Volume
- 102
- Issue
- 4
- Pages
- 647-652
- ISSN
- 0021-9738 (ISSN-L)
- OpenAlex
- W2093647941
- Cited by
- 98
- References
- 4
- FWCI
- 5.63
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.